LMAT logo

LMAT LeMaitre Vascular, Inc.

NASDAQ Global Market · Medical - Instruments & Supplies · Healthcare

$73.61
-1.25 (-1.67%)

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; o…

Market Cap: $1.68Bwww.lemaitre.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
50
4 mentions
—
60d
50
7 mentions
—
90d
50
8 mentions
—
news: 8

Analyst Ratings

20 analysts
Buyconsensus
Strong Buy 0Buy 14Hold 6Sell 0Strong Sell 0
Avg price target$97+31.8%
Low $86Median $95High $110
Current Consensus

Revenue

$67.97M+191.87%
$23.29M$38.99M$54.68M$70.38M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$2.46
$2.36–$2.50
7 analysts
FY2026
$2.79+13% YoY
$2.75–$2.86
6 analysts
FY2027
$3.15+13% YoY
$3.11–$3.20
6 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
George W. LeMaitre
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
651
Beta
0.49
Country
US
Piotroski score
6 / 9 (Middling)
Altman Z-score
6.65
www.lemaitre.com